Kohei Ueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kohei Ueno has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Kazutaka Obama
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
6 shared publicationsMasazumi Sakaguchi
Department of Surgery Kyoto University Kyoto Japan
6 shared publicationsKoya Hida
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4 shared publicationsMichihiro Yamamoto
Department of Gastrointestinal Surgery Tenri Yorozu Hospital Nara Japan
4 shared publicationsSeiichiro Kanaya
Department of Surgery, Japanese Red Cross Osaka Hospital, Osaka, Japan
4 shared publicationsShigeo Hisamori
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4 shared publications
Latest Publications
- Open Access
- 26 July 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (6) , 1732-1742
Return‐To‐Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study
Aim: As survival after gastric and esophageal cancer continues to improve, sustained work participation has become an important survivorship outcome. We aimed to evaluate return‐to‐work (RTW) rates 18 months after curative‐intent surgery for gastric and esophageal cancers and to identify clinical and socioeconomic factors associated with delayed or failed RTW. Methods: This multicenter, longitudinal, prospective cohort study evaluated working‐age Japanese patients undergoing curative‐intent surgery for gastric or esophageal cancer. Working status was assessed preoperatively and at 6, 12, and 18 months postoperatively. The primary outcome was working status at 18 months. Secondary outcomes included time to first RTW, and factors associated with non‐working and delayed RTW. Exploratory analyses evaluated 6‐month patient‐reported outcomes (QLQ‐C30) and postoperative weight loss. Results: Among 158 eligible patients, 124 (78.5%) were working at 18 months. Older age (≥ 65 years) and pathological stage≥ III were associated with non‐working at 18 months, whereas sedentary work and self‐employment were associated with a lower risk of non‐working. Postoperative appetite loss, financial difficulties (QLQ‐C30), and ≥ 10% body weight loss at 6 months were associated with non‐working status. Median time to first RTW was 30 and 70 days for gastric and esophageal cancers, respectively. Esophageal cancer and advanced stage were consistently associated with delayed RTW, with weaker evidence for associations with female sex and preoperative retirement. Conclusions: Approximately 80% of patients were working at 18 months after surgery. Postoperative nutritional impairment and symptom burden were associated with long‐term work participation and may help identify patients at risk of not working after surgery.
- 26 July 2026
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (6) , 1732-1742
Open AccessReturn‐To‐Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study
Aim: As survival after gastric and esophageal cancer continues to improve, sustained work participation has become an important survivorship outcome. We aimed to evaluate return‐to‐work (RTW) rates 18 months after curative‐intent surgery for gastric and esophageal cancers and to identify clinical and socioeconomic factors associated with delayed or failed RTW. Methods: This multicenter, longitudinal, prospective cohort study evaluated working‐age Japanese patients undergoing curative‐intent surgery for gastric or esophageal cancer. Working status was assessed preoperatively and at 6, 12, and 18 months postoperatively. The primary outcome was working status at 18 months. Secondary outcomes included time to first RTW, and factors associated with non‐working and delayed RTW. Exploratory analyses evaluated 6‐month patient‐reported outcomes (QLQ‐C30) and postoperative weight loss. Results: Among 158 eligible patients, 124 (78.5%) were working at 18 months. Older age (≥ 65 years) and pathological stage≥ III were associated with non‐working at 18 months, whereas sedentary work and self‐employment were associated with a lower risk of non‐working. Postoperative appetite loss, financial difficulties (QLQ‐C30), and ≥ 10% body weight loss at 6 months were associated with non‐working status. Median time to first RTW was 30 and 70 days for gastric and esophageal cancers, respectively. Esophageal cancer and advanced stage were consistently associated with delayed RTW, with weaker evidence for associations with female sex and preoperative retirement. Conclusions: Approximately 80% of patients were working at 18 months after surgery. Postoperative nutritional impairment and symptom burden were associated with long‐term work participation and may help identify patients at risk of not working after surgery.
- 29 June 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (9) , 1869-1878
Job resignation between cancer diagnosis and surgery in patients with gastric and esophageal cancer: a multi-institutional cross-sectional study
This multicenter cross-sectional analysis examined the prevalence, risk factors, and health-related quality-of-life (HRQoL) correlates of the job resignation occurring between cancer diagnosis and surgery among patients with gastric or esophageal cancer in Japan. A total of 167 employed patients scheduled for curative-intent surgery across nine institutions between September 2022 and March 2024 completed questionnaires assessing employment status, socioeconomic variables, and preoperative HRQoL, including the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-OG25. Among all participants, 4.2% (7/167) resigned from work prior to surgery. Although exploratory modified Poisson regression did not identify statistically significant predictors, point estimates were higher among women, low-income households, and employees of small companies (≤ 99 workers). Importantly, all patients who resigned expressed willingness to return to work, suggesting factors underlying premature resignation. Exploratory HRQoL comparisons suggested a generally poorer symptom and functioning profile in the resignation group, with a trend toward lower social functioning. These findings suggest the presence of a vulnerable subgroup within this selected perioperative cohort, who may be at risk of losing employment protections and social benefits before surgery. Despite the relatively low prevalence, preoperative job resignation may have profound long-term socioeconomic and psychosocial consequences. Greater attention to employment-related concerns during the preoperative period may help facilitate timely counseling and occupational health interventions to support employment continuity and improve survivorship outcomes.
- 29 June 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (9) , 1869-1878
Job resignation between cancer diagnosis and surgery in patients with gastric and esophageal cancer: a multi-institutional cross-sectional study
This multicenter cross-sectional analysis examined the prevalence, risk factors, and health-related quality-of-life (HRQoL) correlates of the job resignation occurring between cancer diagnosis and surgery among patients with gastric or esophageal cancer in Japan. A total of 167 employed patients scheduled for curative-intent surgery across nine institutions between September 2022 and March 2024 completed questionnaires assessing employment status, socioeconomic variables, and preoperative HRQoL, including the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-OG25. Among all participants, 4.2% (7/167) resigned from work prior to surgery. Although exploratory modified Poisson regression did not identify statistically significant predictors, point estimates were higher among women, low-income households, and employees of small companies (≤ 99 workers). Importantly, all patients who resigned expressed willingness to return to work, suggesting factors underlying premature resignation. Exploratory HRQoL comparisons suggested a generally poorer symptom and functioning profile in the resignation group, with a trend toward lower social functioning. These findings suggest the presence of a vulnerable subgroup within this selected perioperative cohort, who may be at risk of losing employment protections and social benefits before surgery. Despite the relatively low prevalence, preoperative job resignation may have profound long-term socioeconomic and psychosocial consequences. Greater attention to employment-related concerns during the preoperative period may help facilitate timely counseling and occupational health interventions to support employment continuity and improve survivorship outcomes.
- Open Access
- 18 August 2025
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- p. 1-10
Pre- and Post-Operative Exercise and Nutrition Therapy in Patients with Esophageal Cancer Undergoing Esophagectomy: A Prospective Interventional Study
Introduction: This study aimed to evaluate safety and feasibility of perioperative exercise and nutrition therapy and to explore perioperative changes in skeletal muscle mass (SMM) in patients with esophageal cancer. Methods: Patients scheduled for curative esophagectomy at two hospitals were enrolled. Exercise and nutrition therapy were performed for 3 weeks preoperatively and 4 weeks postoperatively. Outcomes included SMM, which was the sum of both mid-thigh cross-sectional area on computed tomography and physical function, assessed at T1 (intervention start), T2 (just before surgery), and T3 (1-month postoperatively). The SMM change rate between T1 and T3 was compared with the hypothesized value (−7.5%) from our previous study. Results: Thirty-six patients underwent intervention and esophagectomy (intervention completion rate: 94.4%, no serious adverse events). The SMM increased by 4.9% for T1–T2 (p < 0.001) but decreased by 10.1% for T1–T3 (p < 0.001), suggesting that the primary outcome was not achieved. Physical function results were significantly better at T3 than at T1. Postoperative SMM loss was lower in patients who maintained postoperative caloric intake and physical activity than in those who could not (−8.3% vs. −15.4%, p = 0.011). Conclusions: Perioperative exercise and nutrition therapy were safe and feasible. An increase in preoperative SMM and postoperative physical function were observed, although SMM decreased after surgery. Further investigation is warranted to evaluate the efficacy of this intervention.
- 18 August 2025
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- p. 1-10
Open AccessPre- and Post-Operative Exercise and Nutrition Therapy in Patients with Esophageal Cancer Undergoing Esophagectomy: A Prospective Interventional Study
Introduction: This study aimed to evaluate safety and feasibility of perioperative exercise and nutrition therapy and to explore perioperative changes in skeletal muscle mass (SMM) in patients with esophageal cancer. Methods: Patients scheduled for curative esophagectomy at two hospitals were enrolled. Exercise and nutrition therapy were performed for 3 weeks preoperatively and 4 weeks postoperatively. Outcomes included SMM, which was the sum of both mid-thigh cross-sectional area on computed tomography and physical function, assessed at T1 (intervention start), T2 (just before surgery), and T3 (1-month postoperatively). The SMM change rate between T1 and T3 was compared with the hypothesized value (−7.5%) from our previous study. Results: Thirty-six patients underwent intervention and esophagectomy (intervention completion rate: 94.4%, no serious adverse events). The SMM increased by 4.9% for T1–T2 (p < 0.001) but decreased by 10.1% for T1–T3 (p < 0.001), suggesting that the primary outcome was not achieved. Physical function results were significantly better at T3 than at T1. Postoperative SMM loss was lower in patients who maintained postoperative caloric intake and physical activity than in those who could not (−8.3% vs. −15.4%, p = 0.011). Conclusions: Perioperative exercise and nutrition therapy were safe and feasible. An increase in preoperative SMM and postoperative physical function were observed, although SMM decreased after surgery. Further investigation is warranted to evaluate the efficacy of this intervention.
- Open Access
- 7 August 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Efficacy of Simple Oral Nutritional Supplements versus Usual Care in Postoperative Patients with Gastric Cancer
Objective: To evaluate the efficacy of a simple oral nutritional supplement (ONS) without excess nutrients on body weight loss (BWL) after gastrectomy in patients with gastric cancer. Summary Background Data: BWL is commonly observed in the early few months after gastrectomy for gastric cancer. It is uncertain if a simple ONS with usual diet improve postoperative BWL. Methods: A multicenter randomized controlled trial was conducted across 19 institutions. Patients undergoing curative gastrectomy for gastric cancer were randomized into the ONS or control group. The ONS group received 400 mL (kcal)/day of ONS mainly containing carbohydrates and proteins for 8 weeks postoperatively. The primary endpoint was the percentage of BWL from baseline to postoperative 8 weeks. Secondary endpoints included handgrip strength, hematological parameters, health-related quality of life, dietary intake, and ONS adherence. Results: The 124 patients were randomized to the ONS group (n=62) or control group (n=62), with 2 in the ONS group lost to follow-up. The ONS group experienced significantly less weight loss at postoperative 8 weeks (−4.8% vs. −6.4%, P=0.039). No significant differences were observed in handgrip strength or hematological parameters. The incidences of adverse events were comparable between the groups (7% vs. 11%, P=0.373), but the ONS group had higher symptom scores for insomnia, appetite loss, and diarrhea during intervention. The mean ONS intake was >75% (308.7 mL±97.0 mL/d). Conclusions: The simple ONS for 8 weeks after gastrectomy reduced postoperative BWL in patients with gastric cancer.
- 7 August 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessEfficacy of Simple Oral Nutritional Supplements versus Usual Care in Postoperative Patients with Gastric Cancer
Objective: To evaluate the efficacy of a simple oral nutritional supplement (ONS) without excess nutrients on body weight loss (BWL) after gastrectomy in patients with gastric cancer. Summary Background Data: BWL is commonly observed in the early few months after gastrectomy for gastric cancer. It is uncertain if a simple ONS with usual diet improve postoperative BWL. Methods: A multicenter randomized controlled trial was conducted across 19 institutions. Patients undergoing curative gastrectomy for gastric cancer were randomized into the ONS or control group. The ONS group received 400 mL (kcal)/day of ONS mainly containing carbohydrates and proteins for 8 weeks postoperatively. The primary endpoint was the percentage of BWL from baseline to postoperative 8 weeks. Secondary endpoints included handgrip strength, hematological parameters, health-related quality of life, dietary intake, and ONS adherence. Results: The 124 patients were randomized to the ONS group (n=62) or control group (n=62), with 2 in the ONS group lost to follow-up. The ONS group experienced significantly less weight loss at postoperative 8 weeks (−4.8% vs. −6.4%, P=0.039). No significant differences were observed in handgrip strength or hematological parameters. The incidences of adverse events were comparable between the groups (7% vs. 11%, P=0.373), but the ONS group had higher symptom scores for insomnia, appetite loss, and diarrhea during intervention. The mean ONS intake was >75% (308.7 mL±97.0 mL/d). Conclusions: The simple ONS for 8 weeks after gastrectomy reduced postoperative BWL in patients with gastric cancer.
- 7 July 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (3) , 556-564
Long‐Term Urinary Dysfunction and Impact on Quality of Life After Rectal Cancer Surgery: A Prospective Multicenter Observational Study
Background and Objectives: We aimed to examine long‐term changes in urinary dysfunction (UD) after rectal cancer surgery, using the three validated assessments: residual urine volume (RUV), International Prostate Symptom Score (IPSS), and International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐SF).Methods: This prospective multicenter observational study was conducted in eight hospitals, and a total of 103 patients, who underwent radical resection for rectal cancer, were included. UD was evaluated at baseline and at 6, 12, and 24 months postoperatively. Quality of life (QoL) was assessed using the European Organization for Research and Treatment Cancer (EORTC) quality of life questionnaire‐core 30 (QLQ‐C30).Results: The proportion of patients with UD based on RUV values decreased from 19.3% at baseline to 7.6% at 24 months (p = 0.022). However, UD, based on IPSS remained relatively constant (33.4% to 29.0%, p = 0.398), whereas UD based on ICIQ‐SF score increased significantly from 17.5% to 29.0% (p = 0.019). Patients with UD, based on both IPSS and ICIQ‐SF, had lower QoL scores at 24 months (mean differences −10.3; p = 0.028 and −15.4; p = 0.001, respectively), whereas RUV values showed no correlation with QoL scores after surgery.Conclusions: RUV values gradually improved postoperatively. However, the impact of higher RUV values on long‐term QoL was limited. UD, based on both IPSS and ICIQ‐SF, persisted after surgery, and negatively affected long‐term QoL.
- 7 July 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 132 (3) , 556-564
Long‐Term Urinary Dysfunction and Impact on Quality of Life After Rectal Cancer Surgery: A Prospective Multicenter Observational Study
Background and Objectives: We aimed to examine long‐term changes in urinary dysfunction (UD) after rectal cancer surgery, using the three validated assessments: residual urine volume (RUV), International Prostate Symptom Score (IPSS), and International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐SF).Methods: This prospective multicenter observational study was conducted in eight hospitals, and a total of 103 patients, who underwent radical resection for rectal cancer, were included. UD was evaluated at baseline and at 6, 12, and 24 months postoperatively. Quality of life (QoL) was assessed using the European Organization for Research and Treatment Cancer (EORTC) quality of life questionnaire‐core 30 (QLQ‐C30).Results: The proportion of patients with UD based on RUV values decreased from 19.3% at baseline to 7.6% at 24 months (p = 0.022). However, UD, based on IPSS remained relatively constant (33.4% to 29.0%, p = 0.398), whereas UD based on ICIQ‐SF score increased significantly from 17.5% to 29.0% (p = 0.019). Patients with UD, based on both IPSS and ICIQ‐SF, had lower QoL scores at 24 months (mean differences −10.3; p = 0.028 and −15.4; p = 0.001, respectively), whereas RUV values showed no correlation with QoL scores after surgery.Conclusions: RUV values gradually improved postoperatively. However, the impact of higher RUV values on long‐term QoL was limited. UD, based on both IPSS and ICIQ‐SF, persisted after surgery, and negatively affected long‐term QoL.
- 31 May 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (6)
Multicentre cohort study on prophylactic supraclavicular lymphadenectomy for lower thoracic oesophageal cancer
- 31 May 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (6)
Multicentre cohort study on prophylactic supraclavicular lymphadenectomy for lower thoracic oesophageal cancer
- 1 January 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 18 (1) , e70145
N‐Shaped Port Placement for Simultaneous Robot‐Assisted Right and Left‐Sided Colectomies
Introduction: Minimally invasive surgery offers significant advantages, including smaller incisions, reduced postoperative pain, and shorter recovery, especially in surgeries requiring access to multiple abdominal quadrants. However, robot‐assisted resection of synchronous colorectal cancer (sCRC) remains technically challenging and unstandardized due to its rarity. Herein, we propose an N‐shaped configuration of five‐trocar placement for the simultaneous right‐ and left‐sided colectomies with intracorporeal anastomosis. Materials and Surgical Technique: An 85‐year‐old woman with synchronous cecal (T1) and sigmoid colon (T3) cancers underwent simultaneous ileocecal resection and sigmoidectomy. A camera trocar at the umbilical incision and four additional trocars were arranged in an N‐shaped configuration. The patient cart was docked from the left caudal side. Right‐sided colectomy was performed first with intracorporeal anastomosis using robotic stapling. Following temporary undocking and a 180‐degree boom rotation, the robotic sigmoidectomy was completed with a standard double‐stapled anastomosis. Total operative time was 311 min with minimal blood loss, and the postoperative course was uneventful. Discussion: This N‐shaped port configuration facilitated a seamless transition between right‐ and left‐sided colectomies, maximizing the advantages of robotic surgery. Importantly, all tasks can be completed with this port configuration by a single patient‐side surgeon. Although further studies are needed to evaluate the adaptability of this approach to other multiport robotic platforms, our experience suggests this technique is practical and effective for multiport robotic sCRC resections.
- 1 January 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 18 (1) , e70145
N‐Shaped Port Placement for Simultaneous Robot‐Assisted Right and Left‐Sided Colectomies
Introduction: Minimally invasive surgery offers significant advantages, including smaller incisions, reduced postoperative pain, and shorter recovery, especially in surgeries requiring access to multiple abdominal quadrants. However, robot‐assisted resection of synchronous colorectal cancer (sCRC) remains technically challenging and unstandardized due to its rarity. Herein, we propose an N‐shaped configuration of five‐trocar placement for the simultaneous right‐ and left‐sided colectomies with intracorporeal anastomosis. Materials and Surgical Technique: An 85‐year‐old woman with synchronous cecal (T1) and sigmoid colon (T3) cancers underwent simultaneous ileocecal resection and sigmoidectomy. A camera trocar at the umbilical incision and four additional trocars were arranged in an N‐shaped configuration. The patient cart was docked from the left caudal side. Right‐sided colectomy was performed first with intracorporeal anastomosis using robotic stapling. Following temporary undocking and a 180‐degree boom rotation, the robotic sigmoidectomy was completed with a standard double‐stapled anastomosis. Total operative time was 311 min with minimal blood loss, and the postoperative course was uneventful. Discussion: This N‐shaped port configuration facilitated a seamless transition between right‐ and left‐sided colectomies, maximizing the advantages of robotic surgery. Importantly, all tasks can be completed with this port configuration by a single patient‐side surgeon. Although further studies are needed to evaluate the adaptability of this approach to other multiport robotic platforms, our experience suggests this technique is practical and effective for multiport robotic sCRC resections.
- Open Access
- 3 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-12
The efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial
Background: Body weight loss (BWL) after gastrectomy impact on the short- and long-term outcomes. Oral nutritional supplement (ONS) has potential to prevent BWL in patients after gastrectomy. However, there is no consistent evidence supporting the beneficial effects of ONS on BWL, muscle strength and health-related quality of life (HRQoL). This study aimed to evaluate the effects of ONS formulated primarily with carbohydrate and protein on BWL, muscle strength, and HRQoL. Methods: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥ II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. Discussion: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. Trial registration: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023.
- 3 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-12
Open AccessThe efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial
Background: Body weight loss (BWL) after gastrectomy impact on the short- and long-term outcomes. Oral nutritional supplement (ONS) has potential to prevent BWL in patients after gastrectomy. However, there is no consistent evidence supporting the beneficial effects of ONS on BWL, muscle strength and health-related quality of life (HRQoL). This study aimed to evaluate the effects of ONS formulated primarily with carbohydrate and protein on BWL, muscle strength, and HRQoL. Methods: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥ II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. Discussion: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. Trial registration: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023.
- Open Access
- 21 September 2023
- Published by Springer Nature in Research Square
The efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial
Background: Oral nutritional supplement (ONS) formulations may lose their flavor because of the complex nutrients used. Many patients who undergo gastrectomy for gastric cancer cannot ingest sufficient amounts of ONS after surgery. Although the use of simpler nutrients in an ONS may improve the flavor, it is unclear if it can prevent the body weight loss (BWL) of patients with gastric cancer after surgery. This study aimed to evaluate the effects of ONS with carbohydrate and protein on BWL, muscle strength, and health-related quality of life (HRQoL). Methods: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. Discussion: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. Trial registration: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023
- 21 September 2023
- Published by Springer Nature in Research Square
Open AccessThe efficacy of simple oral nutritional supplements versus usual care in postoperative patients with gastric cancer: study protocol for a multicenter, open-label, parallel, randomized controlled trial
Background: Oral nutritional supplement (ONS) formulations may lose their flavor because of the complex nutrients used. Many patients who undergo gastrectomy for gastric cancer cannot ingest sufficient amounts of ONS after surgery. Although the use of simpler nutrients in an ONS may improve the flavor, it is unclear if it can prevent the body weight loss (BWL) of patients with gastric cancer after surgery. This study aimed to evaluate the effects of ONS with carbohydrate and protein on BWL, muscle strength, and health-related quality of life (HRQoL). Methods: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. Discussion: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. Trial registration: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023
- 10 July 2023
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2023 (7)
Extensive intraoperative peritoneal lavage for resectable advanced gastric cancer
- 10 July 2023
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2023 (7)
Extensive intraoperative peritoneal lavage for resectable advanced gastric cancer